The role of CREB and other transcription factors in the pharmacotherapy and etiology of depression

References

• Rossby SP, Sulser F. Antidepressants: Beyond the synapse. In: Skolnick Ph, ed. Antidepressants, New Pharmacological Strategies. Totowa, NJ: Humana Press; 1997; 195–212.
   Google Scholar
• Faisst S, Meyers S. Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res 1992; 20: 3–26.
   PubMed Web of Science ®Google Scholar
• Hunter T, Karin M. The regulation of transcription by phosphorylation. Cell 1992; 70: 375–87.
   PubMed Web of Science ®Google Scholar
• Jians DA. The regulation of protein transport to the nucleus by phosphorylation. Biochem J 1995; 311: 705–16.
   PubMed Web of Science ®Google Scholar
• Vandromme M, Gauthier-Rouviere C, Lamb N, Fernandez A. Regulation of transcription factor localization: fine-tuning of gene expression. Trends Bloch Sci 1996; 21: 59–64.
   PubMed Web of Science ®Google Scholar
• Vetulani J, Sulser F. Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP- generating system in limbic forebrain. Nature 1975; 257: 495–6.
   PubMed Web of Science ®Google Scholar
• Verulani J, Stawarz RJ, Sulser F. Adaptive mechanisms of the noradrenergic cyclic AMP generating system in the limbic forebrain of the rat: adaptation to persistent changes in the availability of norepinephrine (NE). J Neurochem 1976; 27: 661–6.
   PubMed Web of Science ®Google Scholar
• Greengard P. The neurobiology of slow synaptic transmis-sion. Science 2001; 294: 1024–30.
   PubMed Web of Science ®Google Scholar
• Benovic JL, Strasser RH, Caron MG, Lefkowitz RJ Beta adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc Nat! Acad Sci USA 1986; 83: 2797–801.
   PubMed Web of Science ®Google Scholar
• Hausdorf WP, Caron MG, Leflcowitz RJ Turning off the signal-desensitizaticn of I3-adrenergic receptor function. FAS-EB J 1993; 4: 2881–8.
   Google Scholar
• Premont RT, Inglese J, Leflcowitz RJ Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J 1995; 9: 175–82.
   Google Scholar
• Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of CREB in rat hippocampus. J Neurosci 1996; 16: 2365–72.
   PubMed Web of Science ®Google Scholar
• Hagiwara M, Brindle P, Harootunian A, Armstrong R, Rivier J, Vale W, et al. Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A. Mol Cell Biol 1993; 13: 4852–9.
   PubMed Web of Science ®Google Scholar
• Nesder EJ, Terwilliger RZ, Duman RS. Chronic antidepres- sant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J Neurochem 1989; 53: 1644–7.
   PubMed Web of Science ®Google Scholar
• Silva AJ, Kogan JH, Frankland PW, Kida S. CREB and Memory. Annu Rev Neurosci 1998; 21: 127–48.
   PubMed Web of Science ®Google Scholar
• Meyer TE, Habener JF. Cyclic adenosine 3',5'-monophos- phate response element binding protein (CREB) and related transcriptional-activatirg deoxyribonucleic acid-binding pro-teins. Endocr Revs 1993; 14: 269–90.
   PubMed Web of Science ®Google Scholar
• Hunter T. Protein Kinases and phosphatases: The yin and yang of protein phosphorylation and signaling. Cell 1995; 80: 225–36.
   PubMed Web of Science ®Google Scholar
• Wadzinski BE, Wheat WH, Jaspers S, Peruski LF Jr, Licicteig RL, Johnson GL, et al. Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation. Mol Cell Biol 1993; 13: 2822–34.
   PubMed Web of Science ®Google Scholar
• Yamamoto KK, Gonzalez GA, Menzel P, Rivier J, Mon- troinY MR. Characterisation of a bipartite activator domain in transcription factor CREB. Cell 1990; 60: 611–7.
   PubMed Web of Science ®Google Scholar
• Manier DH, Shelton RC, Sulser F. Cross-talk between PKA and PKC in human fibroblasts: what are the pharmacothera-peutic implications? J Affect Disord 2001; 65: 275–9.
   Google Scholar
• Rossby SP, Manier DH, Liang S, Nalepa I, Sulser F. Venlafaxine: Pharmacological actions beyond aminergic re-ceptors. Int J Neuropsychopharmacol 1999; 2: 1–8.
   PubMed Web of Science ®Google Scholar
• Manier DH, Shelton RC, Sulser F. Noradrenergic Antide- pressants: Does Chronic Treatment Increase or Decrease Nuclear CREB-P? J Neural Transm 2002; 109: 91–9.
   Google Scholar
• Heydorn WE, Brunswick FT, Frazer A. Effect of treatment of rats with antidepressants on melatonin concentrations in the pineal gland and serum. J Pharmacol Exp Ther 1982; 222: 534–43.
   PubMed Web of Science ®Google Scholar
• Friedman E, Yocca FD, Cooper TD. Antidepressant drugs with varying pharmacological profiles alter rat pineal beta adrenergic mediated function. J Pharmacol Exper Therap 1984; 228: 545–50.
   PubMed Web of Science ®Google Scholar
• Schwaninger M, Schöfl C, Blume R, Rössig L, Knepel W. Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-direc-ted gene transcription. Molec Pharmacol 1995; 47: 1112–8.
   Google Scholar
• Thome J, Sakai N, Shin K, Steffen C, Zhang YJ, Impey S et al. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 2000; 20: 4030–6.
   PubMed Web of Science ®Google Scholar
• Nesder EJ, McMahon A, Sabban EL, Tallman JF, Duman RS. Chronic antidepressant administration decreases the expression of tyrosine hydroxylase in rat locus coeruleus. Proc Nat! Acad Sci USA 1990; 87: 7522–6.
   PubMed Web of Science ®Google Scholar
• Brady LS, Whitfield HJ Jr, Fox RJ, Gold PW, Herkenham M. Long-term antidepressant administration alters cortico-tropin releasing hormone, tyrosine hydroxylase and mineralo-corticoid receptor gene expression in rat brain. J Clin Invest 1991; 87: 831–7.
   PubMed Web of Science ®Google Scholar
• Hosoda K, Duman RS. Regulation of B1-adrenergic receptor mRNA and ligand binding by antidepressant treatments and norepinephrine depletion in rat frontal cortex. J Neurochem 1993; 69: 1335–43.
   Google Scholar
• Wong M, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hor-mone. Proc Nat! Acad Sci USA 2000; 97: 325–30.
   PubMed Web of Science ®Google Scholar
• Montgomery SA. Which antidepressant for which depres-sion? In: Briley M, Montgomery SA, eds. Antidepressant Therapy at the dawn of the third millenium: London: Martin Dunitz; 1998: 333–48.
   Google Scholar
• Kitayama I, Janson AM, Cintra A, Fuxe K, Agnati LF, Ogren SO, et al. Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain. J Neural Transm 1988; 73: 191–203.
   PubMed Web of Science ®Google Scholar
• Budziszewska B, Siwanowicz J, Przegaliiiski E. The effect of chronic treatment with antidepressant drugs on the cortico-steroid receptor levels in the rat hippocampus. Po! J Pharmacol 1994; 46: 147–52.
   Google Scholar
• Peiffer A, Veilleaux S, Barden N. Antidepressant and other centrally acting drugs regulate glucocorticoid receptor mes-senger RNA levels in rat brain. Psychoneuroendocrinology 1991; 16: 505–15.
   PubMed Web of Science ®Google Scholar
• Seckl JR, Fink G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippo-campus in vivo. Neuroendocrinology 1992; 55: 621–6.
   PubMed Web of Science ®Google Scholar
• Rossby SP, Nalepa I, Huang M, Perrin C, Burt A, Schmidt D et al. Norepinephrine-independent regulation of GRIT mRNA in vivo by a tricyclic antidepressant. Brain Res 1995; 687: 79–82.
   PubMed Web of Science ®Google Scholar
• Weigel NL. Steroid hormone receptors and their regulation by phosphorylation. Biochem J 1996; 319: 657–67.
   PubMed Web of Science ®Google Scholar
• O'Malley BW, Onate S, Smith C, Tsai S, Tsai MJ. Molecular Mechanisms of Steroid Receptor Action. In: Fortner JG, Sharp PhA, eds. Accomplishment in Cancer Research: 1996. Phila-delphia: Lippincott-Raven; 1997: 157–67.
   Google Scholar
• O'Malley BW, Tsai MJ. Mechanisms of regulation of gene transcription by steroid receptors. In: Cohen P, Foulkes JG, eds. The hormonal control of gene transcription; Amsterdam: Elsevier; 1991: 101–16.
   Google Scholar
• Beato M. Transcriptional control by nuclear receptors. FASEB J 1991; 5: 2044–51.
   PubMed Web of Science ®Google Scholar
• Eiring A, Sulser F. An increased synaptic availability of norepinephrine is not essential for antidepressant induced increases in hippocampal GR mRNA. J Neural Transm 1997; 104: 1255–8.
   PubMed Web of Science ®Google Scholar
• Honegger U, Disler B, Wiesmann UN. Chronic exposure of human cells in culture to the tricyclic antidepressant desipra-mine reduces the number of beta adrenoceptors. Biochem Pharmacol 1986; 35: 1899–902.
   PubMed Web of Science ®Google Scholar
• Pepin MC, Govindan MV, Barden N. Increased glucocorti- coid receptor gene promoter activity after antidepressant treatment. Mol Pharmacol 1992; 41: 1016–22.
   PubMed Web of Science ®Google Scholar
• Pariante CM, Pearce BD, Pisell TL, Owens MJ, Miller AI-1. Steroid-independent translocation of the glucocorticoid recep-tor by the antidepressant desipramine. Mol Pharmacol 1997; a52: 571–81.
   Google Scholar
• Brown JR, Ye Hong, Bronson T, Dikkes P, Greenberg M. A Defect in Nurturing in Mice Lacking the Immediate Early Gene fosB. Cell 1996; 86: 297–309.
   PubMed Web of Science ®Google Scholar
• Göttlicher M, Heck S, Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J Mol Med 1998; 76: 480–9.
   PubMed Web of Science ®Google Scholar
• Manier DH, Shelton RC, Ellis T, Peterson ChS, Eking A, Sulser E Human fibroblasts as a relevant model of signal transduction in affective disorders. J Affect Disord 2000; 61: 51–8.
   PubMed Web of Science ®Google Scholar
• Shelton R, Manier DH, Sulser F. Cyclic cAMP-dependent protein kinase activity in major depression. Am J Psychiatry 1996; 153: 1037–42.
   PubMed Web of Science ®Google Scholar
• Shelton RC, Manier DH, Ellis T, Peterson ChS, Sulser, F. Cyclic AMP dependent protein kinase in subtypes of major depression and normal volunteers. Int J Neuropsychopharma-col 1999; 3: 187–92.
   Google Scholar
• Rahmann S, Li PP, Young LT, Kofinan O, Kish SJ, Warsh JJ Reduced [3H] cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder. J Neurochem 1997; 68: 297–304.
   PubMed Web of Science ®Google Scholar
• Dwivedi Y, Roberts R, Conley RC, Tamminga C, Pandey GN. Protein kinase A in the postmortem brain of suicide victims. Biol Psychiatry 2000; 47: 248.
   Web of Science ®Google Scholar
• Stone EA. Subsensitivity to noreprinephrine as a link between adaptation to stress and antidepressant therapy: A hypothesis. Res Commun Psycho! Psychiat Behav 1979; 4: 241–55.
   Google Scholar
• Stone EA, Platt JE. Brain Adrenergic Receptors and Resis- tance to Stress. Brain Res 1982; 237: 405–14.
   PubMed Web of Science ®Google Scholar
• Holsboer F, Barden N. Antidepressants and hypothalamic- pituitary-adrenocortical regulation. Endocr Rev 1996; 17: 187–205.
   PubMed Web of Science ®Google Scholar
• Barden N, Ruel J, Holsboer E. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adreno-cortical system? Trends Neurosci 1995; 18: 6–11.
   Google Scholar
• Holsboer F, Barden N. Antidepressants and HPA regulation. Endo cr Rev 1996; 17: 187–203.
   PubMed Web of Science ®Google Scholar
• Nordeen SK, Moyer ML, Bona BJ. The coupling of multiple signal transduction pathways with steroid response mechan-isms. Endocrinology 1994; 134: 1723–32.
   PubMed Web of Science ®Google Scholar
• Duman RS, Vajdya V, Nibuya M, Morinobu S, Fitzgerald L. Stress, Antidepressant Treatments, and Neurotrophic Factors: Molecular and Cellular Mechanisms. Neuroscientist 1995; 1: 351–60.
   Google Scholar
• Duman RS, Nakagawa S, Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychophar-macology 2001; 25: 836–44.
   PubMed Web of Science ®Google Scholar
• Sheline YI, Wang PW, Gado MH, Hsernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Nat! Acad Sci USA 1996; 93: 3908–13.
   PubMed Web of Science ®Google Scholar
• Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Chamey DS. Hippocampal volume reduction in major depression. Am J Psychiatry 2000; 157: 115–7.
   PubMed Web of Science ®Google Scholar
• Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999; 45: 1085–98.
   PubMed Web of Science ®Google Scholar
• Nelson MD, Saykin AJ, Flashman LA, Riordan HI Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging. A meta analytic study. Arch Gen Psychiatry 1998; 55: 433–40.
   PubMed Web of Science ®Google Scholar
• Muller MB, Lucassen PJ, Yassouridis A, Hoogendijk WJG, Holsboer F, Swaab DE. The human fiippocampus in major depression or following administration of glucocorticoids: No evidence for major structural alterations. Soc Neurosci 1998; 24: 990.
   Google Scholar
• Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992; 257: 967–71
   PubMed Web of Science ®Google Scholar
• Watson SJ, Akil H Gene chips and arrays revealed: a primer on their power and their uses. Biol Psychiatry 1999; 45: 533–43.
   PubMed Web of Science ®Google Scholar
• Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH et al. The mood stabilizing agents lithium and valproate robustly increase the expression of the neuroprotective protein bc1-2 in the CNS. J Neurochem 1999; 72: 879–82.
   PubMed Web of Science ®Google Scholar
• Chen G, Huang Li, Zeng W, Manji H. Mood stabilizers regulate cytoprotective and mRNA-binding proteins in the brain: long-term effects on cell survival and transcript stability. Int J Neuropsychopharmacol 2001; 4: 47–64.
   PubMed Web of Science ®Google Scholar
• Wang J, Brown C, Chen B, Young LT. Identification of mood stabilizer-regulated genes by differential-display PCR. Int J Neuropsychopharmacol 2001; 4: 65–74.
   PubMed Web of Science ®Google Scholar
• Wang JF, Brown C, Young LT. Differential display PCR reveals novel targets for the mood stabilizing drug valproate including the molecular chaperone GRP78. Mol Pharmacol 1999; 55: 521–7.
   Google Scholar
• Breviario F, d'Aniello EM, Golay J, Pen i G, Bottazzi B, Bairoch A et al. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. J Biol Chem 1992; 267: 22190–7.
   PubMed Web of Science ®Google Scholar
• Goodman AR, Cardozo T, Abagyan R, Altmeyer A, Wisniewski HG, Vilcek J. Long pentraxins: An emerging group of proteins with diverse functions. Cytokine Growth Factor Rev 1996; 7: 191–202.
   PubMedGoogle Scholar
• Levine MA, Barak Y, Chengappa KNR, Rapoport A, Rebey M, Barak V. Cerebrospinal Cytokine Levels in Patients with Acute Depression. Neuropsychobiology 1999; 40: 171–6.
   PubMed Web of Science ®Google Scholar
• Elkes J. A view through the rear view mirror: Personal beginnings. In anniversary anthology. American College of Neuropsychopharmacology 1986; 181–94.
   Google Scholar
• Sternberg EM. The Balance Within. New York: WH Free-man; 2000.
   Google Scholar
• Lamas M, Sassone-Corsi P. Coupling transcription to signal transduction: CREM and cAMP. In: Papavassilion AG, ed. Transcription Factors in Eukaryotes. Austin, Texas: Landes Bioscience; 1997: 51–65.
   Google Scholar
• Rossby SP, Liang S, Manier DH, Chalcrabarti A, Shelton RC, Sulser F. Molecular psycfiopharmacology as a prelude to a molecular psychopathology of affective disorders; The significance of differential display methodology to study programs of gene expression. In: Briley M, Sulser F, eds. Molecular Genetics of Mental Disorders. London: Martin Dunitz; 2000: 31–46.
   Google Scholar